Barça Innovation Hub invests in Omniscope to develop innovative immunology solutions aimed at optimizing athlete health and performance.
Target Information
Omniscope is an innovative tech start-up that is working to develop the world's largest immune database. The company aims to democratize healthcare by providing access to critical immune data for everyone, thereby unlocking the full potential of the immune system. Utilizing proprietary technologies, Omniscope is dedicated to improving athletic health and performance through advanced data analysis and insights.
The company's patented technologies utilize artificial intelligence (AI) to analyze high-resolution immune cell characterization data. This allows Omniscope to create products specifically designed to enhance athlete resilience, optimize recovery processes, and prevent injuries effectively. Their commitment is not only focused on elite athletes but extends to transforming healthcare access for the general population.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The sports and health sectors are experiencing rapid advancement, particularly within the realm of technology integration. As athletes push their physical limits, the demand for innovative health solutions
Similar Deals
Ferrer → Prilenia Therapeutics B.V.
2024
Neuraxpharm Group → Minoryx Therapeutics
2022
Boston Scientific → Nalu Medical
2026
Barça Innovation Hub
invested in
Omniscope
in 2025
in a Strategic Partnership deal